Notices. Notice
225 words·~1 min read·
/register/2012/12/12/2012-29931·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2011-N-0568] Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Experimental Study: Disease Information in Branded Promotional Material AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is announcing that a collection of information entitled “Experimental Study: Disease Information in Branded Promotional Material” has been approved by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995. FOR FURTHER INFORMATION CONTACT: Daniel Gittleson, Office of Information Management, Food and Drug Administration, 1350 Piccard Dr., PI50-400B, Rockville, MD 20850, 301-796-5156, *Daniel.Gittleson@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: On June 20, 2012, the Agency submitted a proposed collection of information entitled “Experimental Study: Disease Information in Branded Promotional Material” to OMB for review and clearance under 44 U.S.C. 3507. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. OMB has now approved the information collection and has assigned OMB control number 0910-0724. The approval expires on November 30, 2015. A copy of the supporting statement for this information collection is available on the Internet at *http://www.reginfo.gov/public/do/PRAMain.* Dated: December 6, 2012. Leslie Kux, Assistant Commissioner for Policy. [FR Doc. 2012-29931 Filed 12-11-12; 8:45 am]
Connectionstraces to 1
Traces to 1 document